ICN Registers 4 Million Shares
COSTA MESA — ICN Pharmaceuticals Inc. registered more than 4 million shares of its common stock for possible sale by outside shareholders.
The Costa Mesa-based drug maker’s filing with the Securities and Exchange Commission will enable F. Hoffman-La Roche Ltd. to sell the 4.1-million shares it obtained last month in exchange for promissory notes issued when ICN bought worldwide marketing rights for a number of drugs.
In addition, ICN registered 6,959 shares of its stock issued to former owners of Gly-Derm Inc., a company ICN purchased last year.
ICN will not receive any proceeds if the sellers choose to unload their shares.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
